Milner Institute to showcase collaboration and innovation at BioTrinity 2026
We’re delighted to announce that the Milner Therapeutics Institute will play an active role at BioTrinity 2026 next month, with both a dedicated showcase session and participation in a key panel discussion focused on collaboration in life sciences. BioTrinity...
Flagship–Cambridge partnership marks one year of therapeutic innovation and collaboration
In 2025, the Milner Therapeutics Institute, together with Cambridge University Health Partners, announced a collaboration with Flagship Pioneering – a scientific innovation engine for transformative platforms and products in human health, sustainability, and beyond....
Milner Institute hosts Cambridge–Oxford BioVenture Showcase, spotlighting high-potential biotech startups
On 22 January, we were delighted to host the Cambridge–Oxford BioVenture Showcase, bringing together innovators, early‑stage founders, researchers, investors, and industry partners from the Cambridge-Oxford corridor. The showcase created a dynamic forum for...
Milner Therapeutics Institute kickstarts 2026 with business-to-business event for affiliates
Last week, the Milner Institute welcomed more than 45 of its affiliated companies to a business-to-business networking event on the Cambridge Biomedical Campus. The event brought together start-ups from the Milner Bio-incubator and beyond, biotech, services and CRO...
Cathy Tralau-Stewart discusses strengthening UK therapeutic translation in Drug Discovery World
We’re delighted that our Executive Director, Professor Cathy Tralau-Stewart, has continued her thought leadership work with Drug Discovery World, with a timely article on “The role of universities and industry in driving translation of therapeutics: the need for a new...
Functional Genomics Screening Laboratory wins OBN Award for Most Impactful Industry Collaboration
We are thrilled to announce that the Functional Genomics Screening Laboratory (FGSL) has been awarded an OBN Award in the Most Impactful Industry Collaboration category. This recognises the pioneering work taking place in the FGSL — a collaboration between the Milner...
Cathy Tralau-Stewart joins expert panel at 2025 Drug Discovery World Symposium
Milner Executive Director Cathy Tralau-Stewart was delighted to join Drug Discovery World (DDW) at their 2025 Symposium this month, which brought together leaders from drug discovery, academia, and biotech to explore how innovation can move more effectively from...
Milner Therapeutics Institute and Cambridge Network join forces to showcase MTI partnerships and enterprise
Earlier this week, we were delighted to team up with Cambridge Network to host an event at the West Hub in Cambridge. The event provided an overview of the Institute’s unique translational ecosystem, and Cambridge Network members gathered to learn more about the ways...